Top in cardiology: Effects of COVID-19 lockdown, aspirin use and HF risk

During the COVID-19 pandemic lockdown, patients reported an increase in stress and decrease in overall mood and physical activity, according to a recent study. It was the top story in cardiology last week.

Another top story was about a link between heart failure (HF) risk and aspirin use. Study results published in ESC Heart Failure showed that individuals with risk factors for HF who were taking aspirin were 26% more likely to develop HF at 5.3 years than those who did not take aspirin.

Read these and more top stories in cardiology below:

Stress level up, mood and physical activity down during COVID-19 lockdown

The COVID-19 pandemic may have reduced overall mood and physical activity among study participants and increased their levels of self-reported stress, data show. Read more.

Aspirin use associated with 26% increased HF risk in patients with predisposing factors

Among patients with predisposing factors for HF, aspirin use was associated with a 26% increased risk for HF development, researchers reported in ESC Heart Failure. Read more.

In current smokers first CV event could be fatal

New data published in the Journal of the American Heart Association found that current smoking was associated with fatal events caused by myocardial infarction and stroke as first clinical CVD manifestations. Read more.

Stroke survivors less likely to quit smoking than cancer survivors

Compared with cancer survivors, stroke survivors were less likely to quit smoking, with nearly 40% continuing to smoke after the stroke, suggested new data. Read more.

AI-guided arrhythmia diagnostic tool nets FDA clearance for use in pediatric cardiology

Cardiologs announced it received 510(k) clearance from the FDA for use of its artificial intelligence-powered cardiac diagnostics platform in pediatric cardiology. Read more.